This paper examines the strategies and business models adopted by leading players in the international private medical insurance market as well as the key success factors and capabilities required to win and sustain profitable growth in a post-COVID-19 world.

While large for-profit healthcare provider entities with existing capital reserves or greater access to capital markets may be able to weather the financial strain caused by the COVID-19 pandemic, other small, rural, or safety net provider entities may require additional support to keep their doors open.

What are the health insurance options available to the newly unemployed and how may this affect the size of the Affordable Care Act market?

Medicare Shared Savings Program Accountable Care Organizations are especially concerned about the potential for 2020 results to deteriorate due to COVID-19.

What is the impact of COVID-19 on patterns of healthcare utilization, healthcare costs, and population health?

What are some of the cost drivers that healthcare payers may expect to encounter both now and down the road after we get through the initial surge of the COVID-19 pandemic?

Pharmacy benefit managers have moved quickly to develop new policies that provide guidance and assurance to their plan sponsor clients and members amid the coronavirus outbreak.

This report presents the findings of an analysis focused on isolating and estimating the potential financial impact of COVID-19 on hospital indemnity plans in the United States.

Local strategies differ when it comes to fighting COVID-19, and it’s too early to know which strategy- contain or delay- works better.

Where can a health plan’s medical management team contribute to the COVID-19 response?

This article examines COVID-19 implications on current long-term care (LTC) populations, short-term (2020) and long-term (beyond 2020) projection assumptions, and the effects on the LTC industry as a whole.

This article explores the potential effects of the COVID-19 pandemic on the dental industry, considering changes in utilization of dental services that could result from the pandemic and its containment efforts as well as the economic ramifications that are already starting to occur and may last for some time.

This paper examines COVID-19 implications on current long-term care (LTC) insured populations, short-term (2020) and long-term (beyond 2020) projection assumptions, and the effects on the LTC industry as a whole.

The COVID-19 pandemic is placing historic pressures on our healthcare system and coverage programs alike, and Medicaid programs are a key mechanism states are using to address these challenges.

Fast, convenient, cheap, accurate, and widely-used COVID-19 tests can help identify both infected individuals who should self-isolate and those who have recovered, pose low contagion risks, and can help others fight the virus.

This brief identifies five key payer functions likely to be affected by the COVID-19 pandemic and actions payers can take to ensure business continuity while enhancing their contributions to the value chain.

In the wake of the COVID-19 pandemic, could telehealth have the potential to replace some in-person services and better triage care based on needs?

Adjustment of COVID-19 mortality data points & impact on the calibration of mortality models

This survey examines how life insurance carriers are currently reacting to the COVID-19 pandemic.

The personal auto insurance market has taken a unique response to the COVID-19 pandemic and how it has chosen to reflect the impact of the short-term change in driver behavior.

Modeling medical professional liability costs affected by the COVID-19 pandemic is exacerbated by tort law changes, variation in effect among specialties, and an apparent reduction in current claims that may prove to be only a delay contributing to an increase in future reported claim frequency.

With the COVID-19 pandemic, commercial trucking regulations have been eased while other drivers have been mandated to stay off the road.

The onset of COVID-19 and the impact on capital markets pose several challenges for Indian life insurers.

This paper summarises the three main delays that EIOPA recommends regulators offer to provide operational relief to undertakings if so needed during the COVID-19 pandemic.

The economy after COVID-19 may look very different from before the crisis and may involve the use of hitherto unfamiliar fiscal and monetary tools.

How should actuaries think and spend their time in regard to the COVID-19 pandemic?

The COVID-19 pandemic is raising some profound questions for risk practitioners.

This paper discusses actuarial perspectives for the calculation of the capital requirement related to catastrophic pandemic mortality as required by the Solvency II regulation.

Healthcare providers, facilities, and MPL writers can expect direct and indirect impacts from the coronavirus pandemic—with the indirect impact possibly proving more impactful over the long term.

COVID-19 stands to have an impact on the pet insurance industry, but at this point, it is unclear whether that impact is going to be positive or negative.

With the unprecedented challenges presented by the current and future effects of COVID-19, management and directors will need to be cautious with their decisions and consider consequences not presented in prior difficult times.

Firms need to be thinking and acting with dynamism to manage the here and now of the coronavirus pandemic and plan effectively for multiple future scenario pathways.

This article further explores the coronavirus under the lens of a set of key principles we believe are fundamental to effective emerging risk analysis.

With the addition of the global COVID-19 pandemic, an already tumultuous D&O insurance environment has the potential to get much worse.

The Coronavirus Aid, Relief, and Economic Security Act permits a “qualified individual” to certify to the employer that they qualify to elect a coronavirus-related distribution.

A strong understanding of the historical regulatory perspective can serve to inform the discussion on future regulatory changes designed to improve the long-term health of multiemployer pension plans.

On the heels of the dot-com bust from 2000-2002 and the global financial crisis in 2008, can multiemployer plans survive a third “once-in-a-lifetime” event?

This article focuses on the CARES Act provision allowing deferment to January 1, 2021, of required defined benefit contributions due in the 2020 calendar year.

This alert describes Title III (Supporting America’s Health Care System in the Fight Against the Coronavirus), Part II (Access to Healthcare for COVID-19 Patients), Subpart A (Coverage of Testing and Preventive Services), of the CARES Act, which expands upon Division F, Health Provisions, of the Families First Coronavirus Response Act.

The turmoil the COVID-19 pandemic has caused in financial markets raises profound and potentially long-lasting concerns for pension plan sponsors.

While many non-essential businesses are closing temporarily due to government requirements, even leading to staff layoffs in some cases, essential employers in some regions are experiencing the need to increase staffing levels.

As employers are facing the harsh reality of implementing layoffs to maintain economic viability, there may be unintended consequences to various retirement programs, especially pension, post-retirement benefit, and other plans.

These FAQs help you thoughtfully consider the potential effects that market volatility resulting from COVID-19 can have on your plan.

This article contains specific information about what the “Families First Coronavirus Response Act” covers.

The 1,190.95-point Dow decline on February 27, 2020, is the largest we’ve seen in the history of the Dow and amounts to a drop of over 4.4%.